Privatized pharmaceutical innovation vs access to essential medicines: a global framework for equitable sharing of benefits
2017
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Files
Details
Title
Privatized pharmaceutical innovation vs access to essential medicines: a global framework for equitable sharing of benefits
Linking Note
In: Journal of the American Medical Association. - 317(2017), no. 5, pages 473-474
Date
2017
Content Type
Journal Articles
Record Created
2017-03-03
Record ID
294885
Record Appears in